Aquestive Therapeutics (AQST) Net Equity Issued and Repurchased (2020 - 2021)
Aquestive Therapeutics (AQST) posted quarterly Net Equity Issued and Repurchased of $9.9 million for Q1 2021, up 63.35% quarter-over-quarter from $6.1 million in Q4 2020.
Aquestive Therapeutics (AQST) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends
Aquestive Therapeutics' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $9.9 million for Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aquestive Therapeutics | 583.72 Mn | 583.72 Mn | 9.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 9.89 Mn |
| Mar 31, 2021 | 9.89 Mn |
| Dec 31, 2020 | 6.06 Mn |
| Dec 31, 2020 | 6.06 Mn |